🔎 Trials Near Me

Hjem › KOL › Pennsylvania › Philadelphia

KOL kliniske forsøg i Philadelphia, PA

23 studier for KOL søger deltagere på steder i og omkring Philadelphia (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

RekruttererFase 3
  • Research Site, Philadelphia
  • Research Site, Philadelphia
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Suburban Research Associates - Media- Site Number : 8400143, Media · 12 mi væk
Alder 40 til 80 · Alle køn · Opdateret 1. okt. 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

RekruttererFase 2
  • DM Clinical Research - Philadelphia, Philadelphia
Alder 40 til 85 · Alle køn · Opdateret 30. sep. 2026 · NCT07684820

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RekruttererFase 3
  • Temple University Hospital- Site Number : 8400059, Philadelphia
Alder 40 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Rekrutterer
  • Penn Medicine, Philadelphia
  • Temple University, Philadelphia
Alder 40 til 80 · Alle køn · Opdateret 17. sep. 2026 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RekruttererFase 2
  • Research Site, Philadelphia
  • Research Site, Philadelphia
Alder 40 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

RekruttererFase 2
  • Temple University, Philadelphia
Alder 40 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

RekruttererFase 3
  • Research Site, Horsham · 16 mi væk
  • Research Site, Wilmington · 25 mi væk
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RekruttererFase 3
  • Research Site, Philadelphia
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06883305

COPD Exacerbation Follow Up

RekruttererObservationsstudie
  • Thomas Jefferson University, Philadelphia
Alder 40 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07118306

STRIVE Post-Market Registry Study

RekruttererObservationsstudie
  • Temple University, Philadelphia
Alder 18 og opefter · Alle køn · Opdateret 3. aug. 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

RekruttererFase 3
  • GSK Investigational Site, West Chester · 24 mi væk
Alder 40 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07177339

Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

Rekrutterer
  • Temple University Hospital, Philadelphia
Alder 22 og opefter · Alle køn · Opdateret 23. jun. 2026 · NCT07222410

SPIROMICS Study of Early COPD Progression (SOURCE)

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Temple University, Philadelphia
Alder 30 til 55 · Alle køn · Opdateret 3. jun. 2026 · NCT05033990

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

Rekrutterer
  • Temple University - Temple Lung Center, Philadelphia
Alder 40 til 80 · Alle køn · Opdateret 28. apr. 2026 · NCT07051707

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Rekrutterer
  • Temple University, Philadelphia
Alder 40 til 84 · Alle køn · Opdateret 24. apr. 2026 · NCT06891755

Feasibility of Semaglutide in Advanced Lung Disease

RekruttererFase 1/2
  • University of Pennsylvania Perelman School of Medicine, Philadelphia
Alder 18 til 80 · Alle køn · Opdateret 21. apr. 2026 · NCT05746039

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

RekruttererFase 3
  • GSK Investigational Site, Philadelphia
Alder 40 til 80 · Alle køn · Opdateret 9. apr. 2026 · NCT06961214

Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

RekruttererObservationsstudie
  • Thomas Jefferson University, Philadelphia
Alder 50 til 80 · Alle køn · Opdateret 3. mar. 2026 · NCT06974981

Supporting Evidence-based Responses to Emotional Needs in Emphysema

Rekrutterer
  • University of Pennsylvania, Philadelphia
Alder 18 og opefter · Alle køn · Opdateret 30. jan. 2026 · NCT06600126

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

RekruttererObservationsstudie
  • Temple University, Philadelphia
Alder 50 og opefter · Alle køn · Opdateret 5. aug. 2025 · NCT06122077

Temple Health Chest Initiative (THCI 2.0)

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Temple University Of the Commonwealth System of Higher Education, Philadelphia
Alder 50 til 80 · Alle køn · Opdateret 18. apr. 2025 · NCT06933758

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Rekrutterer
  • Jeanes Hospital, Philadelphia
  • Temple University, Philadelphia
Alder 30 og opefter · Alle køn · Opdateret 6. feb. 2025 · NCT05204888

KOL forsøg i andre byer

Andre studier i Philadelphia

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.